Cannabinoid receptor agonist efficacy for stimulating [35S]GTPγS binding to rat cerebellar membranes correlates with agonist-induced decreases in GDP affinity

被引:155
|
作者
Breivogel, CS
Selley, DE
Childers, SR
机构
[1] Wake Forest Univ, Bowman Gray Sch Med, Dept Physiol & Pharmacol, Ctr Neurobiol Invest Drug Abuse, Winston Salem, NC 27157 USA
[2] Wake Forest Univ, Bowman Gray Sch Med, Ctr Investigat Neurosci, Winston Salem, NC 27157 USA
关键词
D O I
10.1074/jbc.273.27.16865
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The relationship between GDP and cannabinoid-stimulated [S-35]guanosine-5'-O-(3-thiotriphosphate) ([S-35]GTP gamma S) binding was investigated in rat cerebellar membranes. Kinetic analyses showed that [35S]GTP gamma S binding reached steady-state levels and that the association rate was increased by the agonist WIN 55212-2 proportional to the concentration of GDP. Dissociation of [S-35]GTP gamma S occurred with two rates (t(1/2) = 7 and 170 min), and WIN 55212-2 increased the proportion of sites exhibiting the faster rate. Without GDP, [S-35]GTP gamma S bound to membranes with high and low affinity, and WIN 55212-2 had no effect. With 30 mu M GDP, [S-35]GTP gamma S bound to low and intermediate affinity sites, and WIN 55212-2 induced high affinity [S-35]GTP gamma S binding without affecting low affinity sites, GDP competed for high affinity [S-35]GTP gamma S binding with high and intermediate affinity in the absence of WIN 55212-2 and with high and low affinity in the presence of WIN 55212-2. Cannabinoid ligands displayed differential abilities to maximally stimulate [S-35]GTP gamma S binding in the presence of GDP. Efficacy differences among ligands increased with increasing GDP concentrations. GDP competition curves revealed that agonists induced low affinity GDP Ki values that were proportional to agonist E-max values, indicating that agonist efficacy is determined by displacement of GDP from G-proteins.
引用
收藏
页码:16865 / 16873
页数:9
相关论文
共 50 条
  • [31] Binding of GTPγ[35S] is regulated by GDP and receptor activation. Studies with the nociceptin/orphanin FQ receptor
    McDonald, John
    Lambert, David G.
    BRITISH JOURNAL OF PHARMACOLOGY, 2010, 159 (06) : 1286 - 1293
  • [32] Serotonin 5-HT1B/1D agonist-stimulated [35S]GTPγS binding in rat and guinea pig striatal membranes
    Mize, AL
    Alper, RH
    BRAIN RESEARCH, 1999, 836 (1-2) : 229 - 236
  • [33] Autoradiographic analysis of dopamine receptor-stimulated [35S]GTPγS binding in rat striatum
    He, L
    Di Monte, DA
    Langston, JW
    Quik, M
    BRAIN RESEARCH, 2000, 885 (01) : 133 - 136
  • [34] Agonist-induced GTP & #61543;[35S] binding appears to be a more sensitive tool to assess group II/III mGluR expression as compared to adenylyl cyclase inhibition
    Lesage, ASJ
    Le Poul, E
    Peeters, L
    Van Gompel, P
    Vanhoenacker, P
    Haegeman, G
    Leysen, JE
    NEUROPHARMACOLOGY, 1999, 38 (10) : A27 - A27
  • [35] Opioid receptor-induced GTPγ35S binding during mouse development
    Nitsche, JF
    Pintar, JE
    DEVELOPMENTAL BIOLOGY, 2003, 253 (01) : 99 - 108
  • [36] Investigation of 5-HT1B receptor function in rat striatal membranes using [35S]GTPγS binding
    Scott, C
    Watson, J
    Middlemiss, DN
    Price, GW
    BRITISH JOURNAL OF PHARMACOLOGY, 2000, 131 : U27 - U27
  • [37] Detailed pharmacological characterization of 5-HT1A-receptor-mediated [35S]GTPγS binding in rat hippocampal membranes
    Odagaki, Y
    Toyoshima, R
    JOURNAL OF PHARMACOLOGICAL SCIENCES, 2005, 98 (01) : 66 - 76
  • [38] Pasteurella multocida toxin facilitates the receptor agonist-induced GTPγS-binding to Gαq in-vitro
    Lang, S
    Orth, J
    Aktories, K
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2005, 371 : R45 - R45
  • [39] α2-Adrenergic receptor-mediated [35S]GTP γ S binding in rat cerebral cortical membranes:: Effects of antagonists
    Odagaki, Yuji
    Toyoshima, Ryoichi
    JOURNAL OF PHARMACOLOGICAL SCIENCES, 2007, 103 : 181P - 181P
  • [40] μ-Opioid receptor and α2-adrenoceptor agonist stimulation of [35S]GTPγS binding to G-proteins in postmortem brains of opioid addicts
    J J Meana
    J González-Maeso
    J A García-Sevilla
    J Guimón
    Molecular Psychiatry, 2000, 5 : 308 - 315